"L'Ospedale Regionale di Lugano ha due sedi (Civico e Italiano) ed è un ospedale pubblico polispecialistico dotato di moderne infrastrutture e di una tecnologia medica all'avanguardia."

During the past decade, Ospedale Regionale di Lugano - Civico; Neurologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Regionale di Lugano - Civico; Neurologia" are "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Primary Progressive" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Ospedale Regionale di Lugano - Civico; Neurologia" in a lesser frequency.

Most popular intervention types in "Ospedale Regionale di Lugano - Civico; Neurologia" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials), "Placebo" (2 trials) and "Fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Regionale di Lugano - Civico; Neurologia" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Regionale di Lugano - Civico; Neurologia". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale Regionale di Lugano - Civico; Neurologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Regionale di Lugano - Civico; Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".